Riskpilot← Back to searchSign inGet full accessEmelie Lind Fysioterapi AB
ABActiveOrg 5590888920Slångatan 9Physiotherapy activities · NACE 8695Est. 20161 employees
Revenue 2025
SEK 1,1M
+9% vs 2024
EBITDA margin
15.0%
+8% vs 2024
Equity ratio
81.5%
Financial strength
Net profit 2025
SEK 95K
+1% vs 2024
| Revenue | SEK 1,1M | +9% |
| EBITDA | SEK 162K | +8% |
| Net profit | SEK 95K | +1% |
| Total assets | SEK 508K | +28% |
| Equity | SEK 414K | +30% |
| Employees | 1 | — |
Legal name
Emelie Lind Fysioterapi AB
Org number
5590888920
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
5 december 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukgymnastikverksamhet, rehab samt bedömning av muskuloskeletala skador samt därmed förenlig verksamhet. Bolaget skall även bedriva viss konsultverksamhet inom hälso- och sjukvård.
Address
Slångatan 9
Email
emelie@arenafysio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 841 | 766 | 814 | 986 | 1 076 |
| Staff expenses | — | −478 | −555 | −568 | −592 |
| EBITDA | −9 | 78 | 12 | 150 | 162 |
| Depreciation & amort. | −42 | −42 | −42 | −42 | −42 |
| EBIT | −51 | 35 | −30 | 107 | 120 |
| Net financials | −2 | −2 | −0 | 0 | −0 |
| Profit before tax | −54 | 33 | −31 | 107 | 119 |
| Tax | −0 | — | — | −13 | −25 |
| Net profit | −54 | 33 | −31 | 94 | 95 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 444 | 354 | 300 | 396 | 508 |
| Equity | 223 | 257 | 226 | 320 | 414 |
| Long-term debt | 53 | 31 | 0 | — | — |
| Short-term debt | 168 | 67 | 74 | 76 | 94 |
| Total debt | 221 | 98 | 74 | 76 | 94 |
EBITDA margin
15.0%
This company
15.8%
Market median
-5% vs market
20212025
Equity ratio
81.5%
This company
38.2%
Market median
+113% vs market
20212025
Return on equity
22.8%
This company
18.4%
Market median
+24% vs market
20212025
Net profit margin
8.8%
This company
8.1%
Market median
+9% vs market
20212025
Asset turnover
2.12×
This company
1.12×
Market median
+89% vs market
20212025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emelie Lind Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emelie Maria Lind | Board of Directors | 0 companies |
| Johan Marcus Lind | Deputy Board Member | 0 companies |